At AWE USA 2026 in Long Beach, California, extended reality researcher José Ferrer Costa reports that the XR conversation is shifting from captivating demos toward operational readiness. The core bottleneck, he notes, is not only performance: it’s governance, infrastructure, and clinical decision-making that determines whether immersive experiences are appropriate, safe, and effective in real care settings.

Costa describes a move toward investing in spatial infrastructure and supporting a broader ecosystem of health care use cases. Yet the path to routine adoption hinges on health systems’ ability to evaluate immersive tools responsibly—timing technical maturity with workflow integration, measurement, and risk oversight.

In a second feature, Luke Taylor examines “NoHarm,” a Brazilian nonprofit AI tool that automates and scales pharmaceutical review. By flagging potentially dangerous drug interactions, incorrect dosages, and other risks at machine speed, the system reduces medication-associated harm while easing pressure on overstretched pharmacists.

Taylor emphasizes that Brazil’s public health scale makes the impact especially consequential: fewer manual bottlenecks can translate into faster, more consistent safety screening. Still, deployment depends on connectivity and data access norms, which vary across regions and influence whether such models can be exported.

Finally, Michelle Falci explores research trends in edge AI paired with flexible, stretchable electronics. Her report frames a future where wearables interpret signals in real time directly on the device, minimizing reliance on cloud processing and improving responsiveness during at-home monitoring.

The technical thesis is that neuromorphic-style computing and efficient on-chip processing can reduce latency and centralized infrastructure demand. In parallel, flexible circuitry may enable sensors to better conform to the body, improving data quality for continuous health tracking.

Together, these features suggest a common viral theme: health innovation is rapidly advancing, but adoption is gated by implementation realities—data pathways, clinical readiness frameworks, and wearable hardware constraints.

Subject of Research: People
Article Title: From Spatial AI to Clinical Readiness: Lessons From Augmented World Expo USA 2026; First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil; The Next Generation of Wearables Won’t Need the Cloud
News Publication Date: July 24, 2026
Web References: https://www.jmir.org/2026/1/e106580 ; https://www.jmir.org/2026/1/e107255 ; https://www.jmir.org/2026/1/e107247
References: Costa JF. From Spatial AI to Clinical Readiness: Lessons From Augmented World Expo USA 2026. J Med Internet Res 2026;28:e106580. doi:10.2196/106580. Taylor L. First, Do NoHarm: How Pharmaceutical AI Is Improving Care Across Brazil. J Med Internet Res 2026;28:e107255. doi:10.2196/107255. Falci M. The Next Generation of Wearables Won’t Need the Cloud. J Med Internet Res 2026;28:e107247. doi:10.2196/107247
Image Credits: Not provided
Keywords: extended reality, clinical readiness, spatial AI, pharmaceutical AI, medication safety, edge AI, wearables, neuromorphic computing, flexible electronics